DSM-5

DSM-5
Name	DSM-5
Author	American Psychiatric Association
Country	United States
Language	English
Subject	Psychiatric classification
Genre	Diagnostic manual
Publisher	American Psychiatric Association
Pub date	2013
Pages	947

DSM-5 The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, is a publication of the American Psychiatric Association that standardizes psychiatric diagnoses used across United States, Canada, United Kingdom, Australia, and other jurisdictions. It succeeded the DSM-IV-TR and influenced clinical practice, research, insurance coding, and international classifications such as the International Classification of Diseases revision processes. The manual was produced by committees composed of experts affiliated with institutions like Harvard University, Johns Hopkins University, University of California, Los Angeles, and Yale University.

History and Development

Development began under the auspices of the American Psychiatric Association with working groups including members from World Health Organization, National Institute of Mental Health, National Institutes of Health, and academic centers such as Columbia University and Stanford University. The revision process involved task forces, field trials, and public comment periods influenced by stakeholders including professional organizations like the American Psychological Association, advocacy groups such as National Alliance on Mental Illness, and regulatory bodies including the Centers for Medicare and Medicaid Services. Historical antecedents trace to earlier editions promulgated after events like the founding of the American Psychiatric Association in the 19th century and diagnostic debates at conferences such as meetings at St. Louis and Geneva that shaped the International Classification of Diseases.

Structure and Organization

The manual is organized into sections and diagnostic criteria sets developed by workgroups comprised of experts from institutions including Massachusetts General Hospital, Mayo Clinic, University College London, and King's College London. It employs a multiaxial legacy restructured into nonaxial documentation reflecting influences from the International Classification of Diseases, 10th Revision and contributions from researchers at Oxford University Press-affiliated centers and departments such as National Institutes of Health laboratories. The book contains sections on diagnostic criteria, descriptive text, prevalence, development and course, risk and prognostic factors, culture-related features, and differential diagnosis, reflecting methodological inputs from peer-reviewed journals including The Lancet, JAMA, and American Journal of Psychiatry.

Major Changes from DSM-IV

Key reforms included the elimination of the multiaxial system used in DSM-IV, creation of new diagnostic entities, and reclassification of several conditions based on evidence from cohort studies at Duke University, University of Pittsburgh, and Vanderbilt University. The manual introduced dimensional assessments influenced by psychometric work from University of Pennsylvania and Northwestern University, merged diagnostic categories informed by research from Karolinska Institutet and McGill University, and revised criteria to harmonize with World Health Organization initiatives and coding used by Centers for Disease Control and Prevention.

Diagnostic Categories and Criteria

Diagnostic chapters cover categories such as neurodevelopmental, schizophrenia spectrum, bipolar and related, depressive, anxiety, obsessive–compulsive and related, trauma- and stressor-related, dissociative, somatic symptom and related, feeding and eating, elimination, sleep–wake, sexual dysfunctions, gender dysphoria, disruptive, impulse-control and conduct, substance-related and addictive, neurocognitive, personality, paraphilic, and other disorders. Criteria sets were informed by empirical studies from institutions such as Columbia University, University of Michigan, University of Toronto, and University of Sydney, and incorporated measurement instruments used in multicenter trials funded by entities like the National Institute on Drug Abuse and the Wellcome Trust.

Controversies and Criticisms

The manual attracted criticism from clinicians, researchers, and advocacy groups including National Alliance on Mental Illness, scholars at Harvard Medical School and King's College London, and ethicists who debated changes at conferences such as meetings of the American Psychiatric Association and international symposia in Geneva and Paris. Critics raised concerns about pathologizing normal variation, pharmaceutical industry influence linked to companies like Pfizer and GlaxoSmithKline, reliability of field trial data from centers such as Columbia University and University of California, San Diego, and cross-cultural applicability in nations represented by delegations to the World Health Organization. Legal and policy implications prompted reviews by agencies including Centers for Medicare and Medicaid Services and tribunals in jurisdictions like European Union member states.

Impact and Usage in Clinical Practice

Clinicians in settings ranging from academic hospitals such as Massachusetts General Hospital and Johns Hopkins Hospital to community clinics affiliated with Veterans Health Administration and managed-care organizations applied DSM-5 criteria for diagnosis, treatment planning, and billing under coding systems harmonized with the International Classification of Diseases, 10th Revision and later revisions. Researchers at universities including University of California, San Diego, University of Washington, and Yale University used DSM-5 criteria in epidemiological studies, randomized controlled trials funded by bodies like the National Institutes of Health, and meta-analyses published in journals such as The New England Journal of Medicine and BMJ.

Editions, Revisions, and Related Manuals

Following initial publication, updates and errata were issued by the American Psychiatric Association and supplemental materials including the DSM-5 Handbook of Differential Diagnosis and the DSM-5 Clinical Cases were produced by publishers and contributors from institutions such as Oxford University Press and Cambridge University Press. Related classification efforts include the International Classification of Diseases, 11th Revision and specialty manuals like the ICD-10-CM adaptations used by national health systems in United States and Australia. Successor activities involved task forces and workgroups convened at meetings in Washington, D.C. and Geneva to monitor clinical utility and guide future revisions.

Category:Psychiatric manuals